These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21934462)

  • 1. Deus ex Makena?
    Das AF; Birch R; Meis PJ
    Obstet Gynecol; 2011 Oct; 118(4):955; author reply 955-6. PubMed ID: 21934462
    [No Abstract]   [Full Text] [Related]  

  • 2. Deus ex Makena?
    Silver RM; Cunningham FG
    Obstet Gynecol; 2011 Jun; 117(6):1263-1265. PubMed ID: 21471852
    [No Abstract]   [Full Text] [Related]  

  • 3. ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth.
    Society for Maternal Fetal Medicine Publications Committee
    Obstet Gynecol; 2008 Oct; 112(4):963-5. PubMed ID: 18827143
    [No Abstract]   [Full Text] [Related]  

  • 4. Progesterone to prevent preterm birth in twin gestations: what is the next step forward?
    Romero R
    BJOG; 2013 Jan; 120(1):1-4. PubMed ID: 23237263
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing preterm births.
    Reprod Biomed Online; 2007 May; 14(5):663. PubMed ID: 17509212
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progesteron--an old--new option in the prevention of preterm birth].
    Rath W
    Z Geburtshilfe Neonatol; 2008 Aug; 212(4):125-6. PubMed ID: 18729034
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy.
    Fang D; Moreno M; Garfield RE; Kuon R; Xia H
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():164-168. PubMed ID: 28777967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone for preterm birth prevention.
    Ransom CE; Murtha AP
    Obstet Gynecol Clin North Am; 2012 Mar; 39(1):1-16, vii. PubMed ID: 22370103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of progesterone and 17-hydroxyprogesterone caproate administration for the prevention of preterm birth: an evidence-based assessment.
    O'Brien JM
    Am J Perinatol; 2012 Oct; 29(9):665-72. PubMed ID: 22773279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option.
    Campbell S
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):1-9. PubMed ID: 21713990
    [No Abstract]   [Full Text] [Related]  

  • 12. Re-analysis of the PREGNANT trial confirms that vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix.
    McKay LA; Holford TR; Bracken MB
    Ultrasound Obstet Gynecol; 2014 May; 43(5):596-7. PubMed ID: 24585456
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC; Mol BW; Bruinse HW
    Ned Tijdschr Geneeskd; 2010; 154():A1730. PubMed ID: 20858311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of randomized controlled trials comparing 17α-hydroxyprogesterone caproate and vaginal progesterone for the prevention of recurrent spontaneous preterm delivery.
    Oler E; Eke AC; Hesson A
    Int J Gynaecol Obstet; 2017 Jul; 138(1):12-16. PubMed ID: 28369874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestational agents for the prevention of preterm birth.
    Lamont RF; Jayasooriya GS
    J Perinat Med; 2009; 37(1):12-4. PubMed ID: 18999914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of progesterone in maternal and fetal medicine.
    Di Renzo GC; Giardina I; Clerici G; Mattei A; Alajmi AH; Gerli S
    Gynecol Endocrinol; 2012 Nov; 28(11):925-32. PubMed ID: 23057618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of preterm birth with vaginal progesterone in women with preterm labor: which are the evidences?].
    Martinez de Tejada B; Othenin-Girard V; Irion O
    Rev Med Suisse; 2015 Oct; 11(492):2004, 2006-8, 2010. PubMed ID: 26672179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogen safety in multiple gestations: application of the Bradford Hill criteria.
    O'Brien JM
    BJOG; 2015 Apr; 122(5):610-4. PubMed ID: 25586892
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth.
    Elimian A; Smith K; Williams M; Knudtson E; Goodman JR; Escobedo MB
    Int J Gynaecol Obstet; 2016 Aug; 134(2):169-72. PubMed ID: 27168167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is in a name? A higher cost!
    Hansen KA
    S D Med; 2011 Jun; 64(6):194-5. PubMed ID: 21710803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.